Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001829126-25-004013
Filing Date
2025-05-28
Accepted
2025-05-28 18:47:14
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 19871
2 EXHIBIT 99.2 cytosorbents_ex99-2.htm EX-99.2 23037
  Complete submission text file 0001829126-25-004013.txt   44800
Mailing Address 305 COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 305 COLLEGE ROAD EAST PRINCETON NJ 08540 973-329-8885
Cytosorbents Corp (Subject) CIK: 0001175151 (see all company filings)

EIN.: 980373793 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-81910 | Film No.: 25997104
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 11 WEST 42ND STREET, 9TH FLOOR NEW YORK NY 10036
Business Address 11 WEST 42ND STREET, 9TH FLOOR NEW YORK NY 10036 212-878-3523
Avenue Venture Opportunities Fund, L.P. (Filed by) CIK: 0001792691 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G